AKERO THERAPEUTICS, INC. - Common Stock (AKRO)
CUSIP: 00973Y108
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 82,872,659
- Total 13F shares
- 31,507,544
- Share change
- +661,936
- Total reported value
- $913,643,371
- Put/Call ratio
- 800%
- Price per share
- $29.01
- Number of holders
- 109
- Value change
- +$20,106,775
- Number of buys
- 50
- Number of sells
- 40
Quarterly Holders Quick Answers
What is CUSIP 00973Y108?
CUSIP 00973Y108 identifies AKRO - AKERO THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00973Y108:
Top shareholders of AKRO - AKERO THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of AKERO THERAPEUTICS, INC. - Common Stock (AKRO) as of Q1 2021
As of 31 Mar 2021,
AKERO THERAPEUTICS, INC. - Common Stock (AKRO) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,507,544 shares.
The largest 10 holders included
ATP Life Science Ventures, L.P., JANUS HENDERSON GROUP PLC, Redmile Group, LLC, ALKEON CAPITAL MANAGEMENT LLC, venBio Partners LLC, HILLHOUSE CAPITAL ADVISORS, LTD., WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, and STATE STREET CORP.
This page lists
109
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
94
Q1 2021 holders
109
Holder diff
15
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.